Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

The purpose of this phase II study was to investigate the efficacy and safety of gemcitabine plus vinorelbine as first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). Eligibility criteria included cytologically or histologically confirmed NSCLC (stage IIIB or IV), no...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of cancer (1990) 2001-03, Vol.37 (5), p.583-590
Hauptverfasser:	Laack, E, Mende, T, Benk, J, Chemaissani, A, Scholtze, J, Lorenz, C, Niestroy, A, Dalhoff, K, Müller, T, Walter, T, Dürk, H, Edler, L, Hossfeld, D.K
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Disease-Free Survival Female Gemcitabine Humans Lung Neoplasms - drug therapy Male Medical sciences Middle Aged Neoplasm Staging Non-small cell lung cancer Pharmacology. Drug treatments Phase II trial Pneumology Survival Analysis Treatment Outcome Tumors of the respiratory system and mediastinum Vinblastine - administration & dosage Vinblastine - analogs & derivatives Vinorelbine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!